Outcome of Board Meeting
Outcome of Board Meeting held on January 29, 201829-01-2018
Novartis man at Trump's Davos dinner will soon helm the Swiss drugmaker
As global leaders pitched their countries at the World Economic Forum (WEF) in Davos, US President Donald Trump had a dinner meeting with a clutch of European business leaders. And among those...26-01-2018
Novartis to expand India R&D unit
Global pharma major Novartis will be expanding its India research and development (R&D) facility located here, increasing space and adding 150 researchers. The R&D centre in Genome Valley...24-01-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Novartis AG24-01-2018
Statement Of Investor Complaints For The Quarter Ended December 31, 2017
Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, please find enclosed statement of investor complaints/grievances for the quarter ended December 31, 2017.19-01-2018
Biocon inks deal with Novartis after US nod for biologic drug
Biocon says the tie-up with Novartis's generics unit Sandoz will focus on developing copies, or biosimilars, of biologic drugs in immunology and oncology18-01-2018
Shareholding for the Period Ended December 31, 2017
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here18-01-2018
Novartis's diclofinac injection flagged by health ministry panel
Troikaa Pharmaceuticals has alleged that Novartis's diclofenac injection, made by Themis Medicare, contains Transcutol, which damages kidneys04-01-2018
Newspaper Publication
In continuation to our letter dated December 29, 2017 please find enclosed copies of Notice of Board Meeting to be held on Monday, January 29, 2018 that was published in the Financial Express and Navshakti on December 30, 2017. The same has been made available on the website of the Company www.novartis.in02-01-2018
Board Meeting On January 29, 2018
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, January 29, 2018; inter-alia to consider unaudited financial results of the Company for the third quarter and nine months ended December 31, 2017....29-12-2017